D.E. Shaw & Co’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $376K | Buy |
+27,432
| New | +$376K | ﹤0.01% | 2619 |
|
|
2024
Q3 | – | Sell |
-10,843
| Closed | -$182K | – | 3485 |
|
|
2024
Q2 | $182K | Buy |
+10,843
| New | +$182K | ﹤0.01% | 2843 |
|
|
2024
Q1 | – | Sell |
-77,873
| Closed | -$1.17M | – | 3418 |
|
|
2023
Q4 | $1.17M | Buy |
77,873
+44,240
| +132% | +$664K | ﹤0.01% | 1998 |
|
|
2023
Q3 | $471K | Buy |
+33,633
| New | +$471K | ﹤0.01% | 2332 |
|